Laparoscopic myomectomy after or without pre-treatment with ulipristal acetate

References

• Parker W. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725–736.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Vergara D, Favilli A, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296(5):855–867.
   PubMed Web of Science ®Google Scholar
• Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol. 2004;16(3):239–243.
   PubMed Web of Science ®Google Scholar
• Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–178.
   PubMed Web of Science ®Google Scholar
• Bhave Chittawar P, Franik S, Pouwer AW, et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014;10:CD004638.
   Google Scholar
• Fukuda M, Tanaka T, Kamada M, et al. Comparison of the perinatal outcomes after laparoscopic myomectomy versus abdominal myomectomy. Gynecol Obstet Invest. 2013;76(4):203–208.
   PubMed Web of Science ®Google Scholar
• Tian YC, Long TF, Dai YM. Pregnancy outcomes following different surgical approaches of myomectomy. J Obstet Gynaecol Res. 2015;41(3):350–357.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Sapia F, Rapisarda AMC, et al. Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int. 2017;2017:6848250.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao J, Li X, et al. The indication and curative effect of hysteroscopic and laparoscopic myomectomy for type II submucous myomas. BMC Surg. 2016;16(1):9.
   PubMedGoogle Scholar
• Donnez J, Arriagada P, Donnez O, et al. Current management of myomas: the place of medical therapy with the advent of selective progesteron receptor modulators. Curr Opin Obstet Gynecol. 2015;27:422–431.
   PubMed Web of Science ®Google Scholar
• Ferrero S, Alessandri F, Vellone VG, et al. Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study. Eur J Obstet Gynecol Reprod Biol. 2016;205:43–47.
   PubMed Web of Science ®Google Scholar
• Luketic L, Shirreff L, Kives S, et al. Does ulipristal acetate affect surgical experience at laparoscopic myomectomy? J Minim Invasive Gynecol. 2017;24(5):797–802.
   PubMed Web of Science ®Google Scholar
• Munro MG, Critchley HO, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding: Malcolm G. Munro, Hilary O.D. Critchley, Ian S. Fraser, for the FIGO Working Group on menstrual disorders. Int J Gynaecol Obstet. 2011;113(1):1–2.
   PubMedGoogle Scholar
• Donnez J, Tomaszewski J, Vazquez F, et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med. 2012;366(5):421–432.
   PubMed Web of Science ®Google Scholar
• Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94(1):324–330.
   PubMed Web of Science ®Google Scholar
• Mara M, Horak P, Kubinova K, et al. Hysteroscopy after uterine fibroid embolization: evaluation of intrauterine findings in 127 patients. J Obstet Gynaecol Res. 2012;38(5):823–831.
   PubMed Web of Science ®Google Scholar
• Shozu M, Murakami K, Segawa T, et al. Successful treatment of symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril. 2003;79(3):628–631.
   PubMed Web of Science ®Google Scholar
• Schwartz L, Rutkowski N, Horan C, et al. Use of transvaginal ultrasonography to monitor the effects of tamoxifen on uterine leiomyoma size and ovarian cyst formation. J Ultrasound Med. 1998;17(11):699–703.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Trespìdi L, Zaina B, et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril. 2003;79(6):1390–1395.
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, PEARL I Study Group, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 2012;366(5):409–420.
   PubMed Web of Science ®Google Scholar
• Sancho JM, Delgado VS, Valero MJ, et al. Hysteroscopic myomectomy outcomes after 3-month treatment with either ulipristal acetate or GnRH analogues: a retrospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2016;198:127–130.
   PubMed Web of Science ®Google Scholar
• Baranowski W. Ulipristal acetate before high complexity endoscopic (hysteroscopic, laparoscopic) myomectomy – a mini-review. Prz Menopauzalny 2016;15:202–204.
   PubMedGoogle Scholar
• Ferrero S, Racca A, Tafi E, et al. Ulipristal acetate before high complexity hysteroscopic myomectomy: a retrospective comparative study. J Minim Invasive Gynecol. 2016;23(3):390–395.
   PubMed Web of Science ®Google Scholar
• de Milliano I, Twisk M, Ket JC, et al. Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: a systematic review and meta-analysis. PLoS One 2017;12(10):e0186158.
   PubMed Web of Science ®Google Scholar
• Oxley SG, Mallick R, Odejinmi F. Laparoscopic myomectomy: an alternative approach to tackling submucous fibroids? J Minim Invasive Gynecol. 2019; pii: S1553-4650(19)30139-6.
   PubMed Web of Science ®Google Scholar
• Yun BS, Seong SJ, Cha DH, et al. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. Eur J Obstet Gynecol Reprod Biol. 2015;191:62–67.
   PubMed Web of Science ®Google Scholar
• Kubinova K, Mara M, Horak P, et al. Reproduction after myomectomy: comparison of patients with and without second-look laparoscopy. Minim Invasive Ther Allied Technol. 2012;21(2):118–124.
   PubMed Web of Science ®Google Scholar